The role of chemotherapy in the management of gastric cancer

Rocco De Vivo, Sandro Pignata, Raffaele Palaia, Valerio Parisi, Bruno Daniele

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Despite a marked decline in the incidence of gastric carcinoma in Western countries, the majority of patients presents with advanced inoperable tumors. In this setting, usually the aim of therapy is palliation, with the exception of chemotherapy administered in the attempt to downstage the tumor and to facilitate potentially curative surgery in patients with locally advanced nonmetastatic disease. This review will focus on the use of chemotherapy for advanced gastric cancer and after curative surgery, providing an overview of future directions for clinical research: preoperative (neoadjuvant) systemic chemotherapy, intraperitoneal treatment, and newer drugs.

Original languageEnglish
Pages (from-to)364-371
Number of pages8
JournalJournal of Clinical Gastroenterology
Volume30
Issue number4
DOIs
Publication statusPublished - Jun 2000

Fingerprint

Stomach Neoplasms
Drug Therapy
Neoplasms
Stomach
Carcinoma
Incidence
Therapeutics
Research
Pharmaceutical Preparations
Direction compound

Keywords

  • Chemotherapy
  • Gastric cancer
  • Review

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The role of chemotherapy in the management of gastric cancer. / De Vivo, Rocco; Pignata, Sandro; Palaia, Raffaele; Parisi, Valerio; Daniele, Bruno.

In: Journal of Clinical Gastroenterology, Vol. 30, No. 4, 06.2000, p. 364-371.

Research output: Contribution to journalArticle

De Vivo, Rocco ; Pignata, Sandro ; Palaia, Raffaele ; Parisi, Valerio ; Daniele, Bruno. / The role of chemotherapy in the management of gastric cancer. In: Journal of Clinical Gastroenterology. 2000 ; Vol. 30, No. 4. pp. 364-371.
@article{fb4ea4929e044912a67964cd937c9e84,
title = "The role of chemotherapy in the management of gastric cancer",
abstract = "Despite a marked decline in the incidence of gastric carcinoma in Western countries, the majority of patients presents with advanced inoperable tumors. In this setting, usually the aim of therapy is palliation, with the exception of chemotherapy administered in the attempt to downstage the tumor and to facilitate potentially curative surgery in patients with locally advanced nonmetastatic disease. This review will focus on the use of chemotherapy for advanced gastric cancer and after curative surgery, providing an overview of future directions for clinical research: preoperative (neoadjuvant) systemic chemotherapy, intraperitoneal treatment, and newer drugs.",
keywords = "Chemotherapy, Gastric cancer, Review",
author = "{De Vivo}, Rocco and Sandro Pignata and Raffaele Palaia and Valerio Parisi and Bruno Daniele",
year = "2000",
month = "6",
doi = "10.1097/00004836-200006000-00004",
language = "English",
volume = "30",
pages = "364--371",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The role of chemotherapy in the management of gastric cancer

AU - De Vivo, Rocco

AU - Pignata, Sandro

AU - Palaia, Raffaele

AU - Parisi, Valerio

AU - Daniele, Bruno

PY - 2000/6

Y1 - 2000/6

N2 - Despite a marked decline in the incidence of gastric carcinoma in Western countries, the majority of patients presents with advanced inoperable tumors. In this setting, usually the aim of therapy is palliation, with the exception of chemotherapy administered in the attempt to downstage the tumor and to facilitate potentially curative surgery in patients with locally advanced nonmetastatic disease. This review will focus on the use of chemotherapy for advanced gastric cancer and after curative surgery, providing an overview of future directions for clinical research: preoperative (neoadjuvant) systemic chemotherapy, intraperitoneal treatment, and newer drugs.

AB - Despite a marked decline in the incidence of gastric carcinoma in Western countries, the majority of patients presents with advanced inoperable tumors. In this setting, usually the aim of therapy is palliation, with the exception of chemotherapy administered in the attempt to downstage the tumor and to facilitate potentially curative surgery in patients with locally advanced nonmetastatic disease. This review will focus on the use of chemotherapy for advanced gastric cancer and after curative surgery, providing an overview of future directions for clinical research: preoperative (neoadjuvant) systemic chemotherapy, intraperitoneal treatment, and newer drugs.

KW - Chemotherapy

KW - Gastric cancer

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=0034038047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034038047&partnerID=8YFLogxK

U2 - 10.1097/00004836-200006000-00004

DO - 10.1097/00004836-200006000-00004

M3 - Article

VL - 30

SP - 364

EP - 371

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 4

ER -